Corporate

Natco Pharma Limited

Natco Pharma Limited has informed the Exchange regarding a press release dated March 03, 2026, titled “NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst®) in the U.S. market”. |SUBJECT: Press Release

Leave a Reply

Your email address will not be published. Required fields are marked *